Oct Antikörper und Ähnliche Produkte
Santa Cruz Biotechnology bietet eine breite Auswahl an Oct-Antikörpern zum Nachweis der Oct-Familie von Transkriptionsfaktoren. Oct-Antikörper eignen sich für zahlreiche Forschungsanwendungen, darunter Western Blotting (WB), Immunpräzipitation (IP), Immunfluoreszenz (IF), Immunhistochemie mit Paraffineinbettungen (IHCP), Durchflusszytometrie (FCM) und Enzymimmunoassay (ELISA). Oct-Transkriptionsfaktoren, insbesondere Oct4, sind für die Aufrechterhaltung der Pluripotenz und Selbsterneuerung in embryonalen Stammzellen von grundlegender Bedeutung. Oct-Transkriptionsfaktoren regulieren die Genexpression während der Entwicklung, was sie zu wichtigen Zielen in der regenerativen Medizin und der Krebsforschung macht. Das Verständnis der Oct-Transkriptionsfaktoren fördert das Wissen über zelluläre Differenzierungs- und Reprogrammierungsprozesse. Oct-Antikörper ermöglichen den präzisen Nachweis und die Analyse der Expressionsmuster und Interaktionen von Oct-Proteinen. Oct-Antikörper unterstützen die Untersuchung von Stammzellenerhaltung, Differenzierungswegen und Entwicklungsprozessen. Die monoklonalen Antikörper von Santa Cruz Biotechnology für Oct-Proteine ermöglichen es Forschern weltweit, bedeutende Entdeckungen in der Stammzellbiologie und Transkriptionsregulation zu machen.
Oct Antikörper
| Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|---|
Oct-1 Antikörper (12F11) | sc-8024 | mouse IgG1 κ | 462-760 (Xenopus laevis) | WB, IP, IF, IHC(P) | m, r, h and Xenopus laevis | 47 | ||
Oct-1 Antikörper (0.T.100) | sc-71744 | mouse IgG1 κ | FL (h) | WB, IP | m, r, h | 2 | ||
Oct-1 Antikörper (E-8) | sc-28334 | mouse IgM κ | 679-743 (h) | WB, IP, IF, ELISA | h | 3 | ||
Oct-1 Antikörper (YL15) | sc-53830 | mouse IgG1 κ | FL (h) | WB, IP, ELISA | m, r, h | 1 | ||
Oct-2 Antikörper (PT2) | sc-56822 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P), ELISA | h | 4 | ||
Oct-2 Antikörper (D-12) | sc-365116 | mouse IgM κ | 435-463 (h) | WB, IP, IF, ELISA | m, r, h | 2 | ||
Oct-2 Antikörper (F-5) | sc-377475 | mouse IgG1 κ | 435-463 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 2 | ||
Oct-2 Antikörper (H-3) | sc-377476 | mouse IgG2b κ | 435-463 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 2 | ||
Oct3/4 Antikörper (C-10) | sc-5279 | mouse IgG2b κ | 1-134 (h) | WB, IP, IF, IHC(P), FCM, ELISA | m, r, h | 2,693 | ||
Oct3/4 Antikörper (A-9) | sc-365509 | mouse IgG1 λ | 16-45 (h) | WB, IP, IF, ELISA | m, r, h | 21 | ||
Oct3/4 Antikörper (1) | sc-101534 | mouse IgG1 κ | FL (h) | WB, IP, ELISA | m, r, h | 16 | ||
Oct3/4 Antikörper (F-7) | sc-514295 | mouse IgG2b κ | 331-360 (h) | WB, IP, IF, ELISA | m, r, h | 3 | ||
Oct-6 Antikörper (B-7) | sc-376143 | mouse IgG2a κ | 111-160 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 2 | ||
Oct-6 Antikörper (A-8) | sc-376093 | mouse IgG1 κ | 111-160 (h) | WB, IP, IF, ELISA | m, r, h | neu |
Oct CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
Oct-1 HDR Plasmid (h) | sc-401156-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Oct-1 CRISPR/Cas9 KO Plasmid (m) | sc-422347 | m | Gene Knockout | GFP | 0 | ||
Oct-1 HDR Plasmid (m) | sc-422347-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Oct3/4 CRISPR/Cas9 KO Plasmid (h) | sc-410951 | h | Gene Knockout | GFP | 0 | ||
Oct3/4 CRISPR/Cas9 KO Plasmid (h2) | sc-400012-KO-2 | h | Gene Knockout | GFP | 0 | ||
Oct3/4 HDR Plasmid (h) | sc-410951-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Oct3/4 HDR Plasmid (h2) | sc-400012-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
Oct3/4 Double Nickase Plasmid (h) | sc-400012-NIC | h | Gene Knockout | Puromycin | 0 | ||
Oct3/4 Double Nickase Plasmid (h) | sc-410951-NIC | h | Gene Knockout | Puromycin | 0 | ||
Oct3/4 Double Nickase Plasmid (h2) | sc-400012-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Oct3/4 Double Nickase Plasmid (h2) | sc-410951-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Oct3/4 CRISPR/Cas9 KO Plasmid (m) | sc-422357 | m | Gene Knockout | GFP | 0 | ||
Oct3/4 HDR Plasmid (m) | sc-422357-HDR | m | Homology Directed Repair | Puromycin | 0 |
Oct CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
Oct-1 CRISPR Activation Plasmid (h) | sc-401156-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Oct-6 CRISPR Activation Plasmid (h) | sc-401826-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Oct3/4 CRISPR Activation Plasmid (h) | sc-400012-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Oct3/4 CRISPR Activation Plasmid (h) | sc-410951-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Oct3/4 CRISPR Activation Plasmid (h2) | sc-400012-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Oct3/4 CRISPR Activation Plasmid (h2) | sc-410951-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Oct3/4 Lentiviral Activation Particles (h) | sc-400012-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Oct3/4 Lentiviral Activation Particles (h2) | sc-400012-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Oct3/4 CRISPR Activation Plasmid (m) | sc-422357-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 |
Oct siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
Oct-1 siRNA (h) | sc-36119 | h | Gene Silencing | N/A | 8 | ||
Oct-1 shRNA Plasmid (h) | sc-36119-SH | h | Gene Silencing | Puromycin | 8 | ||
Oct-1 shRNA (h) Lentivirale Partikel | sc-36119-V | h | Gene Silencing | Puromycin | 8 | ||
Oct-1 siRNA (m) | sc-36120 | m | Gene Silencing | N/A | 5 | ||
Oct-1 shRNA Plasmid (m) | sc-36120-SH | m | Gene Silencing | Puromycin | 5 | ||
Oct-1 shRNA (m) Lentivirale Partikel | sc-36120-V | m | Gene Silencing | Puromycin | 5 | ||
Oct-2 siRNA (h) | sc-36121 | h | Gene Silencing | N/A | 1 | ||
Oct-2 shRNA Plasmid (h) | sc-36121-SH | h | Gene Silencing | Puromycin | 1 | ||
Oct-2 shRNA (h) Lentivirale Partikel | sc-36121-V | h | Gene Silencing | Puromycin | 1 | ||
Oct-2 siRNA (m) | sc-36122 | m | Gene Silencing | N/A | 0 | ||
Oct-2 shRNA Plasmid (m) | sc-36122-SH | m | Gene Silencing | Puromycin | 0 | ||
Oct-2 shRNA (m) Lentivirale Partikel | sc-36122-V | m | Gene Silencing | Puromycin | 0 | ||
Oct-6 siRNA (h) | sc-38774 | h | Gene Silencing | N/A | 0 | ||
Oct-6 shRNA Plasmid (h) | sc-38774-SH | h | Gene Silencing | Puromycin | 0 | ||
Oct-6 shRNA (h) Lentivirale Partikel | sc-38774-V | h | Gene Silencing | Puromycin | 0 | ||
Oct-6 siRNA (m) | sc-38775 | m | Gene Silencing | N/A | 0 | ||
Oct-6 shRNA Plasmid (m) | sc-38775-SH | m | Gene Silencing | Puromycin | 0 | ||
Oct-6 shRNA (m) Lentivirale Partikel | sc-38775-V | m | Gene Silencing | Puromycin | 0 | ||
Oct3/4 siRNA (h) | sc-36123 | h | Gene Silencing | N/A | 16 | ||
Oct3/4 siRNA (h2) | sc-43980 | h | Gene Silencing | N/A | 1 | ||
Oct3/4 shRNA Plasmid (h) | sc-36123-SH | h | Gene Silencing | Puromycin | 16 | ||
Oct3/4 shRNA Plasmid (h) | sc-43980-SH | h | Gene Silencing | Puromycin | 1 | ||
Oct3/4 shRNA (h) Lentivirale Partikel | sc-36123-V | h | Gene Silencing | Puromycin | 16 | ||
Oct3/4 shRNA (h) Lentivirale Partikel | sc-43980-V | h | Gene Silencing | Puromycin | 1 | ||
Oct3/4 siRNA (m) | sc-36124 | m | Gene Silencing | N/A | 4 | ||
Oct3/4 shRNA Plasmid (m) | sc-36124-SH | m | Gene Silencing | Puromycin | 4 | ||
Oct3/4 shRNA (m) Lentivirale Partikel | sc-36124-V | m | Gene Silencing | Puromycin | 4 |
Oct Oligonucleotides
| Empty Table Header | Produkt | Übereinstimmende Katalognummer | Katalognummer Mutante | Übereinstimmung Mutante | Bindungsstelle | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
Oct-1 consensus oligonucleotide | sc-2506 | sc-2515 | 5’-TGT CGA ATG CAA ATC ACT AGA A-3’ | "AT"→"GC" | 75 |